Communicable disease threats report, 14-20 October 2012, week 42
The ECDC communicable disease threats report is a weekly bulletin intended for epidemiologists and health professionals in the area of communicable disease prevention and control.
Communicable Disease Threats Report, 3-9 June 2018, week 23
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 June 2018 and includes updates on dengue, Vibrio growth in the Baltic Sea, measles, rubella, hepatitis A, mass gathering monitoring, Carbapenem-resistant Enterobacteriaceae, Ebola virus disease, West Nile virus, polio and MERS-CoV.
- Carbapenem-resistant Enterobactericae
- Democratic Republic of the Congo
- Ebola haemorrhagic fever
- Ebola outbreak - North Kivu, Ituri, DRC
- Hepatitis A
- La Réunion
- Middle East respiratory syndrome coronavirus
- Public health threat
- West Nile virus infection
Communicable disease threats report, 8-14 July 2018, week 28
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 July 2018 and includes updates on carbapenemase-producing (OXA-48) Klebsiella pneumoniae, dengue, Ebola virus disease, poliomyelitis, MERS-CoV, mass gathering monitoring (FIFA Men's Football World Cup), measles, poliovirus type 2, rubella, Vibrio growth in the Baltic Sea, and West Nile virus.
Communicable disease threats report, 28 July-3 August 2019, week 31
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 28 July to 3 August 2019 and includes updates on Middle East respiratory syndrome coronavirus (MERS-CoV), Ebola virus disease, monitoring environmental sustainability of Vibrio growth in the Baltic Sea and West Nile virus infection.
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
Harausz, E.P., Garcia-Prats, A.J., Law, S., Schaaf, H.S., Kredo, T., Seddon, J.A., Menzies, D., Turkova, A., Achar, J., Amanullah, F., Barry, P., Becerra, M., Chan, E.D., Chan, P.C., Ioana Chiotan, D., Crossa, A., Drobac, P.C., Fairlie, L., Falzon, D., Flood, J., Gegia, M., Hicks, R.M., Isaakidis, P., Kadri, S.M., Kampmann, B., Madhi, S.A., Marais, E., Mariandyshev, A., Méndez-Echevarría, A., Moore, B.K., Nargiza, P., Ozere, I., Padayatchi, N., ur-Rehman, S., Rybak, N., Santiago-Garcia, B., Shah, N.S., Sharma, S., Shim, T.S., Skrahina, A., Soriano-Arandes, A., van den Boom, M., van der Werf, M.J., van der Werf, T.S., Williams, B., Yablokova, E., Yim, J.-J., Furin, J., Hesseling, A.C.
- Drug-resistant tuberculosis
- HIV infection
- Multidrug resistance
- Multidrug-resistant tuberculosis
- Prevention and control
- South Africa
- South Korea
- United Kingdom
- United States